Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido
NCT00566384
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Libido
Interventions
DRUG:
Dehydroepiandrosterone, BAY86-5314
DRUG:
Placebo
Sponsor
Bayer